INTERNATIONAL PATENT: PAUL SCHERRER INSTITUT, UNIVERSITAT BERN FILES APPLICATION FOR "CD30-TARGETING ANTIBODY-RADIOLIGAND CONJUGATES AND THEIR THERAPEUTIC USE"

GENEVA, Dec. 1 -- PAUL SCHERRER INSTITUT (5232 Villigen), UNIVERSITAT BERN (Verwaltungsdirektion Hochschulstrasse 63012 Bern) filed a patent application (PCT/EP2025/064380) for "CD30-targeting antibody-radioligand conjugates and their therapeutic use" on May 23, 2025. With publication no. WO/2025/242909, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RIOJA BLANCO, Elisa (Hochstrasse 698044 Zurich), BEHE, Martin (Hauptstrasse 6b4466 Ormalingen), GRZMIL, Michal Piotr (Gellertstrasse 974052 Basel), SCHIBLI, Roger (Schartenr...